Search results
Pharma lobbying for weight loss drugs could soon pay off
Yahoo Finance· 10 months agoThe recent surge in popularity of weight loss and Type 2 diabetes drugs Wegovy, Ozempic, and...
Monroe County drug maker Catalent to cut 130 jobs. What we know
The Herald-Times via Yahoo News· 2 months agoDrug maker Catalent is cutting 130 jobs in Bloomington. The company said in an emailed statement the...
Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making
Motley Fool via Yahoo Finance· 2 weeks agoThe pharmaceutical industry is currently experiencing something of a renaissance thanks to the rise...
AstraZeneca Makes A Break For A Buy Point On Massive Third-Quarter Growth
Investor's Business Daily· 2 years agoAstraZeneca leaned on cancer and diabetes drugs in the third-quarter, leading to double-digit sales...
Interested in the Weight-Loss Market? Here's 1 Stock to Buy Hand Over Fist in 2024, and 1 to Avoid...
Motley Fool via Yahoo Finance· 5 months agoWhen it comes to the pharmaceutical industry, weight-loss medications are all the rage right now....
After Wegovy's Approval to Treat Heart Disease, Novo Nordisk Continues to Make Moves
Motley Fool via Yahoo Finance· 1 month agoDiabetes and obesity care are two engines fueling the pharmaceutical industry right now. Novo...
Can TikTok Do for Peloton What It Did for Novo Nordisk and Ozempic?
Motley Fool via Yahoo Finance· 4 months agoPeloton Interactive (NASDAQ: PTON) needs a growth catalyst badly. The company's bikes were hot buys...
AstraZeneca To Acquire Blood-Pressure Drugmaker In $1.8 Billion Deal
Investor's Business Daily· 1 year agoAstraZeneca on Monday said it has agreed to buy CinCor Pharma, maker of clinical-stage blood...
How the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand’ for weight-loss...
Fortune via Yahoo Finance· 2 weeks agoGood morning. At least one sector has shrugged off the current economic uncertainty, and now the...
Merck Stock Surges After Winning Patent Battle Vs. Viatris Over Two Key Drugs
Investor's Business Daily· 2 years agoMerck stock jumped Thursday after the company won a patent battle against generic-drug maker Viatris...